Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy.
Sci China Life Sci
; 66(10): 2310-2328, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37115491
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Programmed Cell Death 1 Receptor
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci China Life Sci
Year:
2023
Document type:
Article